24.31USD+8.38%Mkt Cap: 98.35M USDP/E: —Last update: 2026-06-01
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap98.35M USD
Enterprise Value74.60M USD
Revenue (TTM)32.73M USD
Gross Profit-2.11M USD
Net Income (TTM)-26.60M USD
Revenue/Share8.750 USD
Last Price24.31 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees29
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS22978P1066
Valuation
P/E (Trailing)—
P/E (Forward)-45.63
PEG—
EV/EBITDA-4.11
EV/Revenue2.28
P/S2.71
P/B3.30
EPS (TTM)-4.53
EPS (Forward)-0.48
52W Range
4.98053% of range41.42
52W High41.42 USD
52W Low4.980 USD
Profitability
Gross Margin-6.45%
Oper. Margin-94.32%
EBITDA Margin-55.49%
Profit Margin-96.85%
ROE-100.64%
ROA-63.02%
Growth
Revenue Growth1250.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.69M USD
CapEx (TTM)177.00K USD
FCF Margin-41.57%
FCF Yield-13.83%
Net Debt-14.00M USD
Net Debt/EBITDA0.77
Balance Sheet
Debt/Equity0.16
Current Ratio3.57
Quick Ratio3.34
Book Value/Sh6.638 USD
Cash/Share4.311 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:30
Split DateApr 24, 2026
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)115.00 USD
Target Range115.00 USD – 115.00 USD
# Analysts1
Ownership
Shares Out.4.05M
Float3.61M
Insiders8.55%
Institutions17.63%
Short Interest
Short Ratio0.2d
Short % Float6.90%
Short % Out.6.31%
Shares Short255.16K
Short (prev mo.)251.40K
Technical
SMA 5017.53 (+38.7%)
SMA 20016.76 (+45.0%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)999.39K
Avg Vol (10d)123.37K
Technical Indicators
RSI (14)50.9
MACD0.4062
MACD Signal1.3956
MACD Hist.-0.9894
BB Upper38.01 USD
BB Middle26.37 USD
BB Lower14.73 USD
BB Width88.26%
ATR (14)4.042 USD
Vol Ratio (20d)0.04x